Fiberoptic Intubation: Steps and Usage

Fiberoptic intubation (FOI) is a valuable technique for managing difficult airways in both anticipated and unanticipated scenarios. This method allows for direct visualization of the airway anatomy and precise placement of the endotracheal tube, making it particularly useful in patients with challenging airway characteristics. FOI can be performed on awake or anesthetized patients, with the awake technique being preferred for those with anticipated difficult airways. This article reviews the uses of fiberoptic intubation and the steps involved with the procedure.

The procedure begins with thorough patient preparation. Equipment, including the flexible fiberoptic bronchoscope, endotracheal tube, lubricant, and suction, is assembled. The patient is positioned either supine or seated, and standard airway and emergency equipment are made available. An antisialagogue, such as glycopyrrolate, may be administered if not contraindicated in order to reduce saliva flow. Supplemental oxygen is provided to ensure adequate oxygenation throughout the procedure.

Topical anesthesia is a crucial piece of the steps in fiberoptic intubation, especially for awake patients. This typically involves nebulizing lidocaine to anesthetize the oropharynx, applying lidocaine gel to the nasal passages if using a nasal approach, and spraying lidocaine to the posterior pharynx and larynx. Thorough topical anesthesia enhances patient comfort and cooperation during the procedure.

The actual intubation process involves several steps when using fiberoptic equipment. First, the bronchoscope is inserted through the nose or mouth. It is then carefully advanced while identifying anatomical landmarks. The vocal cords and tracheal rings are visualized, and additional local anesthetic may be sprayed through the scope as needed. The scope is passed through the vocal cords into the trachea, followed by advancing the endotracheal tube over the bronchoscope. Tube position is confirmed visually and with end-tidal CO2 monitoring. Finally, the bronchoscope is removed while holding the tube in place, and the tube is secured and connected to the ventilator.

FOI has various clinical applications. It is particularly useful in patients with limited mouth opening, cervical spine instability, airway tumors or masses, obesity with sleep apnea, and facial trauma or burns. The technique can be performed nasally or orally, with the nasal approach being advantageous in cases of large tongue, limited mouth opening, or when an unobstructed surgical field is beneficial.

While FOI is generally safe, it is not without potential complications. These may include difficulty navigating through secretions or blood, patient anxiety or intolerance of the procedure (in awake cases), equipment malfunction, and nasal bleeding when using the nasal approach. More serious complications, though rare, can include laryngospasm, bronchospasm, and oversedation leading to respiratory depression or airway obstruction. There is also a risk of trauma to airway structures and aspiration, particularly if laryngeal reflexes are compromised. Fiberoptic intubation is a highly useful tool for airway management but requires multiple steps, meaning that other techniques, such as direct laryngoscopy, may be preferred in straightforward cases.

The success of FOI relies on thorough preparation, appropriate patient selection, and skilled execution. As with any advanced airway technique, regular practice and ongoing education are crucial for maintaining proficiency. When the steps are performed correctly, fiberoptic intubation provides a safe and effective method for securing the airway in a wide range of clinical scenarios.

References

1. Collins SR, Blank RS. Fiberoptic intubation: an overview and update. Respir Care. 2014 Jun;59(6):865-78; discussion 878-80. doi: 10.4187/respcare.03012. PMID: 24891196.

2. Calder I. Murphy P. A fibre-optic endoscope used for nasal intubation. Anaesthesia 1967; 22: 489-91. Anaesthesia. 2010 Nov;65(11):1133-6. doi: 10.1111/j.1365-2044.2010.06535.x. PMID: 20946391.

3. Practice guidelines for management of the difficult airway. A report by the American Society of Anesthesiologists Task Force on Management of the Difficult Airway. Anesthesiology. 1993 Mar;78(3):597-602. PMID: 8457062.

4. Geffin B. Anesthesia and the “problem upper airway”. Int Anesthesiol Clin. 1990;28(2):106-114. PMID: 10604785.

5. Rosenberg PH, Heinonen J, Takasaki M. Lidocaine concentration in blood after topical anaesthesia of the upper respiratory tract. Acta Anaesthesiol Scand. 1980 Apr;24(2):125-8. doi: 10.1111/j.1399-6576.1980.tb01519.x. PMID: 7386144.